• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Noncoding RNAs Serve as the Deadliest Universal Regulators of all Cancers.非编码 RNA 是所有癌症最致命的通用调控因子。
Cancer Genomics Proteomics. 2021 Jan-Feb;18(1):43-52. doi: 10.21873/cgp.20240.
2
The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma.假基因衍生的长链非编码RNA SFTA1P在肺腺癌中表达下调并抑制细胞迁移和侵袭。
Tumour Biol. 2017 Feb;39(2):1010428317691418. doi: 10.1177/1010428317691418.
3
A-to-I RNA editing as a tuner of noncoding RNAs in cancer.A-to-I RNA 编辑作为癌症中非编码 RNA 的调节剂。
Cancer Lett. 2020 Dec 1;494:88-93. doi: 10.1016/j.canlet.2020.08.004. Epub 2020 Aug 19.
4
Noncoding RNAs endogenously rule the cancerous regulatory realm while proteins govern the normal.非编码RNA在体内调控着癌性调节领域,而蛋白质则调控着正常领域。
Comput Struct Biotechnol J. 2022 Apr 20;20:1935-1945. doi: 10.1016/j.csbj.2022.04.015. eCollection 2022.
5
Noncoding RNAs in disease.非编码 RNA 与疾病
FEBS Lett. 2018 Sep;592(17):2884-2900. doi: 10.1002/1873-3468.13182. Epub 2018 Jul 20.
6
Molecular fossils "pseudogenes" as functional signature in biological system.分子化石“假基因”作为生物系统中的功能特征。
Genes Genomics. 2020 Jun;42(6):619-630. doi: 10.1007/s13258-020-00935-7. Epub 2020 Apr 10.
7
The interplay between m6A RNA methylation and noncoding RNA in cancer.m6A RNA 甲基化与癌症中非编码 RNA 的相互作用。
J Hematol Oncol. 2019 Nov 22;12(1):121. doi: 10.1186/s13045-019-0805-7.
8
Directional association test reveals high-quality putative cancer driver biomarkers including noncoding RNAs.定向关联测试揭示了高质量的潜在癌症驱动生物标志物,包括非编码 RNA。
BMC Med Genomics. 2019 Dec 30;12(Suppl 7):129. doi: 10.1186/s12920-019-0565-9.
9
An expanding universe of noncoding RNAs between the poles of basic science and clinical investigations.非编码 RNA 在基础科学和临床研究两极之间的不断扩展的领域。
Epigenomics. 2016 Mar;8(3):317-9. doi: 10.2217/epi.15.65. Epub 2015 Sep 29.
10
Interplay between regulation by methylation and noncoding RNAs in cancers.癌症中甲基化调控与非编码RNA之间的相互作用。
Eur J Cancer Prev. 2018 Jul;27(4):418-424. doi: 10.1097/CEJ.0000000000000433.

引用本文的文献

1
The Primary Role of Noncoding RNA in the Pathogenesis of Cancer.非编码RNA在癌症发病机制中的主要作用
Genes (Basel). 2025 Jun 30;16(7):771. doi: 10.3390/genes16070771.
2
Noncoding RNAs evolutionarily extend animal lifespan.非编码RNA在进化上可延长动物寿命。
Glob Med Genet. 2024 Dec 7;12(2):100034. doi: 10.1016/j.gmg.2024.100034. eCollection 2025 Jun.
3
Conceptual breakthroughs of the long noncoding RNA functional system and its endogenous regulatory role in the cancerous regime.长链非编码RNA功能系统的概念性突破及其在癌症状态下的内源性调控作用
Explor Target Antitumor Ther. 2024;5(1):170-186. doi: 10.37349/etat.2024.00211. Epub 2024 Feb 27.
4
Ambiguous genes due to aligners and their impact on RNA-seq data analysis.由于Aligner 导致的模糊基因及其对 RNA-seq 数据分析的影响。
Sci Rep. 2023 Dec 8;13(1):21770. doi: 10.1038/s41598-023-41085-6.
5
Distinctive functional regime of endogenous lncRNAs in dark regions of human genome.人类基因组暗区中内源性长链非编码RNA的独特功能机制。
Comput Struct Biotechnol J. 2022 May 16;20:2381-2390. doi: 10.1016/j.csbj.2022.05.020. eCollection 2022.
6
Noncoding RNAs endogenously rule the cancerous regulatory realm while proteins govern the normal.非编码RNA在体内调控着癌性调节领域,而蛋白质则调控着正常领域。
Comput Struct Biotechnol J. 2022 Apr 20;20:1935-1945. doi: 10.1016/j.csbj.2022.04.015. eCollection 2022.
7
Pseudogene AK4P1 promotes pancreatic ductal adenocarcinoma progression through relieving miR-375-mediated YAP1 degradation.假基因AK4P1通过减轻miR-375介导的YAP1降解促进胰腺导管腺癌进展。
Aging (Albany NY). 2022 Feb 27;14(4):1983-2003. doi: 10.18632/aging.203921.
8
Noncoding RNAs and Deep Learning Neural Network Discriminate Multi-Cancer Types.非编码RNA与深度学习神经网络可鉴别多种癌症类型。
Cancers (Basel). 2022 Jan 12;14(2):352. doi: 10.3390/cancers14020352.

本文引用的文献

1
FINET: Fast Inferring NETwork.FINET:快速推理网络。
BMC Res Notes. 2020 Nov 10;13(1):521. doi: 10.1186/s13104-020-05371-0.
2
Genomic basis for RNA alterations in cancer.癌症中 RNA 改变的基因组基础。
Nature. 2020 Feb;578(7793):129-136. doi: 10.1038/s41586-020-1970-0. Epub 2020 Feb 5.
3
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.分析 2658 个癌症全基因组中的非编码体细胞驱动因子。
Nature. 2020 Feb;578(7793):102-111. doi: 10.1038/s41586-020-1965-x. Epub 2020 Feb 5.
4
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.Hippo 通路效应物 YAP 和 TAZ 的瘤周激活抑制小鼠肝癌。
Science. 2019 Nov 22;366(6468):1029-1034. doi: 10.1126/science.aaw9886.
5
Advances in epigenetics link genetics to the environment and disease.表观遗传学的进展将遗传学与环境和疾病联系起来。
Nature. 2019 Jul;571(7766):489-499. doi: 10.1038/s41586-019-1411-0. Epub 2019 Jul 24.
6
Emerging Roles of p53 Related lncRNAs in Cancer Progression: A Systematic Review.p53 相关长链非编码 RNA 在癌症进展中的新兴作用:系统评价。
Int J Biol Sci. 2019 May 12;15(6):1287-1298. doi: 10.7150/ijbs.33218. eCollection 2019.
7
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
8
The chromatin accessibility landscape of primary human cancers.原发性人类癌症的染色质可及性图谱。
Science. 2018 Oct 26;362(6413). doi: 10.1126/science.aav1898.
9
A role for chromatin regulatory dynamics in breast cancer evolution.
Nat Med. 2018 Sep;24(9):1309-1311. doi: 10.1038/s41591-018-0182-8.
10
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.TCGA 泛癌临床数据资源整合,推动高质量生存预后分析。
Cell. 2018 Apr 5;173(2):400-416.e11. doi: 10.1016/j.cell.2018.02.052.

非编码 RNA 是所有癌症最致命的通用调控因子。

Noncoding RNAs Serve as the Deadliest Universal Regulators of all Cancers.

机构信息

The Institute for Integrative Genome Biology, University of California at Riverside, Riverside, CA, U.S.A.;

The Institute for Integrative Genome Biology, University of California at Riverside, Riverside, CA, U.S.A.

出版信息

Cancer Genomics Proteomics. 2021 Jan-Feb;18(1):43-52. doi: 10.21873/cgp.20240.

DOI:10.21873/cgp.20240
PMID:33419895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7796816/
Abstract

Numerous cancer drivers have been identified, but they are specific to a given cancer type and condition; universal cancer drivers and universal cancer mechanisms still remain largely unclear. Here, we identified the deadliest universal drivers for all cancers via developing algorithms to analyze massive RNAseqs and clinical data from The Cancer Genome Atlas (TCGA). In general, noncoding RNAs primarily serve as the most important inducers and suppressors for all types of cancers. In particular, pseudogenes are primary inducers, and specifically the antisense RNA RP11-335K5.2 serves as the most universal cancerous driver, independently of the cancer type and condition. Therefore, noncoding RNAs, instead of proteins as conventionally thought, primarily drive cancer, which establishes a novel field for future cancer research and therapy.

摘要

已经发现了许多癌症驱动因素,但它们是特定于给定的癌症类型和状况的;普遍的癌症驱动因素和普遍的癌症机制仍然很大程度上不清楚。在这里,我们通过开发算法来分析来自癌症基因组图谱(TCGA)的大量 RNAseq 和临床数据,确定了所有癌症的最致命的普遍驱动因素。一般来说,非编码 RNA 主要作为所有类型癌症的最重要的诱导剂和抑制剂。特别是假基因是主要的诱导剂,特别是反义 RNA RP11-335K5.2 作为最普遍的致癌驱动因素,独立于癌症类型和状况。因此,非编码 RNA,而不是蛋白质,主要驱动癌症,这为未来的癌症研究和治疗开辟了一个新的领域。